ES2056851T3 - Preparacion de terfenadina polimorficamente pura. - Google Patents

Preparacion de terfenadina polimorficamente pura.

Info

Publication number
ES2056851T3
ES2056851T3 ES88106898T ES88106898T ES2056851T3 ES 2056851 T3 ES2056851 T3 ES 2056851T3 ES 88106898 T ES88106898 T ES 88106898T ES 88106898 T ES88106898 T ES 88106898T ES 2056851 T3 ES2056851 T3 ES 2056851T3
Authority
ES
Spain
Prior art keywords
preparation
polymorphically pure
terfenadine
pure terfenadine
polymorphically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88106898T
Other languages
English (en)
Inventor
Timothy G Fawcett
Christian T Goralski
David W Ziettlow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8198929&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2056851(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2056851T3 publication Critical patent/ES2056851T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

TETRAFENADINA POLIMORFICAMENTE PURA, 1-(P-TETRA-BUTIFENIL)-4-[4-((ALFA)HIDROXIDIFENILMETIL)-1-PIPERIDINIL]BUTANOL, SE PREPARA POR METODOS DE RECRISTALIZACION SEGURAMENTE CONTROLADOS.
ES88106898T 1988-04-29 1988-04-29 Preparacion de terfenadina polimorficamente pura. Expired - Lifetime ES2056851T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP88106898A EP0339118B1 (en) 1988-04-29 1988-04-29 Preparation of polymorphically pure terfenadine

Publications (1)

Publication Number Publication Date
ES2056851T3 true ES2056851T3 (es) 1994-10-16

Family

ID=8198929

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88106898T Expired - Lifetime ES2056851T3 (es) 1988-04-29 1988-04-29 Preparacion de terfenadina polimorficamente pura.

Country Status (8)

Country Link
US (1) US4742175A (es)
EP (1) EP0339118B1 (es)
AR (1) AR243612A1 (es)
AT (1) ATE107283T1 (es)
CA (1) CA1312610C (es)
DE (1) DE3850244T2 (es)
DK (1) DK173555B1 (es)
ES (1) ES2056851T3 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4742175A (en) * 1986-05-07 1988-05-03 Merrell Dow Pharmaceuticals Inc. Preparation of polymorphically pure terfenadine
IT1217837B (it) * 1988-06-17 1990-03-30 Lepetit Spa Procedimento per la preparazione del "alfa /4(1,1 dimetiletil)fenil/piperidinbutanolo"
ZA901360B (en) * 1989-02-28 1990-11-28 Merrell Dow Pharma Preparation of the low-melting polymorphic form of terfenadine
ZA903145B (en) * 1989-05-01 1991-02-27 Merrell Dow Pharma Process for the preparation of the high melting polymorphic form of terfenadine
US5247092A (en) * 1989-12-29 1993-09-21 Erregierre Industria Chimica S.P.A. Preparation of the high-melting polymorph of terfenadine
FR2681861B1 (fr) * 1991-10-01 1995-06-09 Isochem Sa Procede de preparation d'une forme polymorphique de la terfenadine, a point de fusion eleve, d'une plus grande purete et produit obtenu.
US5347006A (en) * 1992-12-31 1994-09-13 Augusto Lavacchielli Method of preparing a polymorph of terfenadine
EP0703902B1 (en) * 1993-06-24 1998-12-16 Albany Molecular Research, Inc. Process for the production of piperidine derivatives
US20020007068A1 (en) * 1999-07-16 2002-01-17 D'ambra Thomas E. Piperidine derivatives and process for their production
US6147216A (en) * 1993-06-25 2000-11-14 Merrell Pharmaceuticals Inc. Intermediates useful for the preparation of antihistaminic piperidine derivatives
JP3712208B2 (ja) 1993-06-25 2005-11-02 メレルファーマスーティカルズ インコーポレイテッド 抗ヒスタミン性の４−ジフェニルメチル／ジフェニルメトキシピペリジン誘導体類を製造する新規な中間体
IT1270829B (it) * 1993-09-17 1997-05-13 Recordati Chem Pharm Procedimento per la preparazione di polimorfo i della terfenadina con distribuzione granulometrica ottimale
US20030045722A1 (en) * 1994-05-18 2003-03-06 Henton Daniel R. Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
CN1148849A (zh) * 1994-05-18 1997-04-30 赫彻斯特马里恩鲁斯公司 抗组胺哌啶衍生物，其多晶形物和假同晶物的无水和水合物形式的制备方法
US6153754A (en) * 1995-12-21 2000-11-28 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US6201124B1 (en) 1995-12-21 2001-03-13 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US6194431B1 (en) 1998-04-14 2001-02-27 Paul D. Rubin Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
US6613907B2 (en) 2000-11-08 2003-09-02 Amr Technology, Inc. Process for the production of piperidine derivatives with microorganisms
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
WO2007056457A2 (en) 2005-11-09 2007-05-18 Combinatorx, Incorporated Methods, compositions, and kits for the treatment of medical conditions
WO2010021681A2 (en) * 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US20110130711A1 (en) * 2009-11-19 2011-06-02 Follica, Inc. Hair growth treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3878217A (en) * 1972-01-28 1975-04-15 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
ZA728544B (en) * 1972-01-28 1974-02-27 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
US4742175A (en) * 1986-05-07 1988-05-03 Merrell Dow Pharmaceuticals Inc. Preparation of polymorphically pure terfenadine

Also Published As

Publication number Publication date
DK173555B1 (da) 2001-03-12
AR243612A1 (es) 1993-08-31
CA1312610C (en) 1993-01-12
DK210888A (da) 1989-10-19
DE3850244D1 (de) 1994-07-21
ATE107283T1 (de) 1994-07-15
EP0339118B1 (en) 1994-06-15
DK210888D0 (da) 1988-04-18
EP0339118A1 (en) 1989-11-02
DE3850244T2 (de) 1994-10-06
US4742175A (en) 1988-05-03

Similar Documents

Publication Publication Date Title
ES2056851T3 (es) Preparacion de terfenadina polimorficamente pura.
DK104292D0 (da) Heterocycliske forbindelser og fremgangsmaade til deres fremstilling
NO164093C (no) Pyridinoksyd-mellomprodukter og fremgangsmaate for deres fremstilling.
NO911696L (no) Polypeptider.
FI884877A0 (fi) Produktion av m-csf.
DK520784A (da) Cycliske polypeptider, deres fremstilling og anvendelse
DE68913054D1 (de) Verwendung von 4-substituierten-Imidazol-Derivaten in der perioperativen Medikation.
ES427728A1 (es) Procedimiento para la obtencion de imidazolil-o, n-acetales.
EP0627241A3 (en) Voltage regulator for pacemakers.
ATE46146T1 (de) Phenylpiperidinderivat und seine salze, ihre herstellung, sie enthaltende zusammensetzungen und ihre therapeutische verwendung.
DK0474517T3 (da) Hidtil ukendt anvendelse af 1alfa-hydroxyleret-19-nor-vitamin D-
ATE154388T1 (de) Verwendung von modifiziertem heparin kofaktor ii
ES481633A1 (es) Un procedimiento de preparacion de derivados de 4-fenil-2- tiazolil-oxamato.
AU5902690A (en) Novel 3-methoximinopropionic esters and fungicides containing them
UA19151A (uk) Спосіб одержаhhя оптичhо активhого (+)-4-деметоксидауhоміциhоhу
ATE92318T1 (de) Isolierung von castanospermin und dessen verwendung als antidiabetisches heilmittel.
NO864635D0 (no) Nye krystallinske salter av aryloksyfenolaminer og deres fremstilling.
DK82787A (da) Triazolderivat og fremgangsmaade til fremstilling deraf samt plantevaekstregulerende middel indeholdende derivatet og derivatets anvendelse
DE69122376D1 (de) Hochreine Thrombinzubereitung
ES2051792T3 (es) Proceso para preparar alfa-(alquilfenil)-4-(hidroxidifenilmetil)-1-piperidina butanol.
EP0365213A3 (en) Method of resolving cis 3-amino-4-[2-(2-furyl)vinyl]-1-methoxy-carbonylmethyl-azetidin-2-one and di-p-toluoyl-tartaric acid salts thereof
NO980309L (no) Nye, anti-konvulsive imidazolin-2,4-dioner med en ortosubstituert ar(alk)yl-rest i 1-stilling, og deres fremstilling
ATE62693T1 (de) Waermedefibrinogenierung eines ahf-praeparates.
UA26390A (uk) 5- або 6-заміщеhі складhі ефіри бета-карболіh-3-карбоhової кислоти, які проявляють психотропhу активhість, та фармацевтичhий препарат для лікуваhhя психотропhих захворюваhь
DE69029069D1 (de) Verwendung von Xanthinderivaten gegen Magengeschwüre

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 339118

Country of ref document: ES